ArticleClinical rheumatology2026
Transition of adolescents with JIA to adult rheumatology: what is the most suitable time?
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION/
objectivesImproved long term outcomes in juvenile idiopathic arthritis (JIA) have increased the demand for transition to adult rheumatology care [1]. There is a need for evaluation criteria that can be used in this process. In this study, the Transition Readiness Assessment Questionnaire (TRAQ) was applied to patients with JIA to identify clinical factors associated with transition readiness and determine most appropriate time frame for transition.
methodThis cross-sectional study included 115 adolescents with JIA followed in the Department of Pediatric Rheumatology at Dokuz Eylül University between 2021 and 2023. Patients were divided into two age groups (14-15 and 16-18 years) to compare TRAQ scores and demographic, clinical characteristics. TRAQ scores were categorized by percentile values; multivariable logistic regression and ROC analyses were performed to identify independent predictors and the age associated with high transition readiness.
resultsAmong 115 adolescents with JIA, 54 (47%) were aged 14-15 years and 61 (53%) were aged 16-18 years; 58 (50.4%) were female. Total TRAQ and subscale scores were significantly higher in the 16-18 age group, except for the "tracking health issues" subscale. In multivariate analysis, age was the only independent predictor associated with both high and low TRAQ scores. ROC analysis identified 17.5 years as the optimal cutoff value for predicting high TRAQ scores.
conclusionsAlthough transition readiness increased with age and was higher in patients aged 16-18 years, initiating transition education at age 14 may support a more effective transition process, reduce transition related anxiety and improve follow-up quality. Key Points • Transition readiness was significantly higher in adolescents aged 16-18 years, with age as the strongest independent predictor of TRAQ scores. • The findings support early transition education beginning around the age of 14 years in adolescents with JIA. • ROC analysis identified 17.5 years as the age most strongly associated with higher transition readiness.
Indexed as
Identifiers
42773401What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.